These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 32948843)
1. IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction-a retrospective propensity score analysis. Kattih B; Shirvani A; Klement P; Garrido AM; Gabdoulline R; Liebich A; Brandes M; Chaturvedi A; Seeger T; Thol F; Göhring G; Schlegelberger B; Geffers R; John D; Bavendiek U; Bauersachs J; Ganser A; Heineke J; Heuser M Leukemia; 2021 May; 35(5):1301-1316. PubMed ID: 32948843 [TBL] [Abstract][Full Text] [Related]
2. Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients. Chotirat S; Thongnoppakhun W; Promsuwicha O; Boonthimat C; Auewarakul CU J Hematol Oncol; 2012 Mar; 5():5. PubMed ID: 22397365 [TBL] [Abstract][Full Text] [Related]
3. Isocitrate dehydrogenase 1 and 2 mutations, 2-hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemia. Brunner AM; Neuberg DS; Wander SA; Sadrzadeh H; Ballen KK; Amrein PC; Attar E; Hobbs GS; Chen YB; Perry A; Connolly C; Joseph C; Burke M; Ramos A; Galinsky I; Yen K; Yang H; Straley K; Agresta S; Adamia S; Borger DR; Iafrate A; Graubert TA; Stone RM; Fathi AT Cancer; 2019 Feb; 125(4):541-549. PubMed ID: 30422308 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and Clinical Effect of IDH1 and IDH2 Mutations Among Cytogenetically Normal Acute Myeloid Leukemia Patients. Aref S; Kamel Areida el S; Abdel Aaal MF; Adam OM; El-Ghonemy MS; El-Baiomy MA; Zeid TA Clin Lymphoma Myeloma Leuk; 2015 Sep; 15(9):550-5. PubMed ID: 26189213 [TBL] [Abstract][Full Text] [Related]
5. IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication. Paschka P; Schlenk RF; Gaidzik VI; Habdank M; Krönke J; Bullinger L; Späth D; Kayser S; Zucknick M; Götze K; Horst HA; Germing U; Döhner H; Döhner K J Clin Oncol; 2010 Aug; 28(22):3636-43. PubMed ID: 20567020 [TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia with IDH1 or IDH2 mutation: frequency and clinicopathologic features. Patel KP; Ravandi F; Ma D; Paladugu A; Barkoh BA; Medeiros LJ; Luthra R Am J Clin Pathol; 2011 Jan; 135(1):35-45. PubMed ID: 21173122 [TBL] [Abstract][Full Text] [Related]
7. Potential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis. Zhou KG; Jiang LJ; Shang Z; Wang J; Huang L; Zhou JF Leuk Lymphoma; 2012 Dec; 53(12):2423-9. PubMed ID: 22616558 [TBL] [Abstract][Full Text] [Related]
8. Additional mutations in IDH1/2-mutated patients with acute myeloid leukemia. Lu J; Chen M; Hua H; Qin W; Zhang R; Lu X; Chao H Int J Lab Hematol; 2021 Dec; 43(6):1483-1490. PubMed ID: 34270876 [TBL] [Abstract][Full Text] [Related]
9. [Analysis of IDH1 and IDH2 mutations in patients with acute myeloid leukemia]. Jia ZX; Zhou M; Chao HY; Lu XZ; Zhang R; Cen L; Xiao R; Jiang NK Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):397-401. PubMed ID: 22781800 [TBL] [Abstract][Full Text] [Related]
10. Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value. Abbas S; Lugthart S; Kavelaars FG; Schelen A; Koenders JE; Zeilemaker A; van Putten WJ; Rijneveld AW; Löwenberg B; Valk PJ Blood; 2010 Sep; 116(12):2122-6. PubMed ID: 20538800 [TBL] [Abstract][Full Text] [Related]
11. IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. Lin J; Yao DM; Qian J; Chen Q; Qian W; Li Y; Yang J; Wang CZ; Chai HY; Qian Z; Xiao GF; Xu WR Ann Hematol; 2012 Apr; 91(4):519-25. PubMed ID: 21997850 [TBL] [Abstract][Full Text] [Related]
12. Mutation Analysis of IDH1/2 Genes in Unselected De novo Acute Myeloid Leukaemia Patients in India - Identification of A Novel IDH2 Mutation. Raveendran S; Sarojam S; Vijay S; Geetha AC; Sreedharan J; Narayanan G; Sreedharan H Asian Pac J Cancer Prev; 2015; 16(9):4095-101. PubMed ID: 25987093 [TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics in adult acute myeloid leukemia with isocitrate dehydrogenase gene mutation]. Wang RX; Wu DP; Chen SN; He J; Xu Y; Wang XL; Yin J; Tian H; Tian XP; Sun AN Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(10):751-5. PubMed ID: 23755812 [TBL] [Abstract][Full Text] [Related]
14. Aberrant HIF1- α and SIX-1 Expression is Associated with Poor Prognosis in Acute Myeloid Leukemia Patients with Isocitrate Dehydrogenase 1 Mutations. Ali T; Usman R; Shah SA; Parvez A; Anwar S; Muneer Z; Saeed M Cancer Control; 2024; 31():10732748241271714. PubMed ID: 39110525 [TBL] [Abstract][Full Text] [Related]
15. Adverse impact of IDH1 and IDH2 mutations in primary AML: experience of the Spanish CETLAM group. Nomdedéu J; Hoyos M; Carricondo M; Esteve J; Bussaglia E; Estivill C; Ribera JM; Duarte R; Salamero O; Gallardo D; Pedro C; Aventin A; Brunet S; Sierra J Leuk Res; 2012 Aug; 36(8):990-7. PubMed ID: 22520341 [TBL] [Abstract][Full Text] [Related]
16. IDH1 and IDH2 mutations confer an adverse effect in patients with acute myeloid leukemia lacking the NPM1 mutation. Yamaguchi S; Iwanaga E; Tokunaga K; Nanri T; Shimomura T; Suzushima H; Mitsuya H; Asou N Eur J Haematol; 2014 Jun; 92(6):471-7. PubMed ID: 24443894 [TBL] [Abstract][Full Text] [Related]
17. IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status. Schnittger S; Haferlach C; Ulke M; Alpermann T; Kern W; Haferlach T Blood; 2010 Dec; 116(25):5486-96. PubMed ID: 20805365 [TBL] [Abstract][Full Text] [Related]
18. Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study. Ho PA; Alonzo TA; Kopecky KJ; Miller KL; Kuhn J; Zeng R; Gerbing RB; Raimondi SC; Hirsch BA; Oehler V; Hurwitz CA; Franklin JL; Gamis AS; Petersdorf SH; Anderson JE; Reaman GH; Baker LH; Willman CL; Bernstein ID; Radich JP; Appelbaum FR; Stirewalt DL; Meshinchi S Leukemia; 2010 May; 24(5):909-13. PubMed ID: 20376086 [TBL] [Abstract][Full Text] [Related]
19. Serum 2-hydroxyglutarate production in IDH1- and IDH2-mutated de novo acute myeloid leukemia: a study by the Acute Leukemia French Association group. Janin M; Mylonas E; Saada V; Micol JB; Renneville A; Quivoron C; Koscielny S; Scourzic L; Forget S; Pautas C; Caillot D; Preudhomme C; Dombret H; Berthon C; Barouki R; Rabier D; Auger N; Griscelli F; Chachaty E; Leclercq E; Courtier MH; Bennaceur-Griscelli A; Solary E; Bernard OA; Penard-Lacronique V; Ottolenghi C; de Botton S J Clin Oncol; 2014 Feb; 32(4):297-305. PubMed ID: 24344214 [TBL] [Abstract][Full Text] [Related]
20. Investigation of Isocitrate Dehydrogenase 1 and 2 Mutations in Acute Leukemia Patients in Saudi Arabia. Alkhatabi H; Bin Saddeq HA; Alyamani L; Shinawi T; Yasin EB; Alserihi R; Felimban R; Tayeb HH; Mimani R; Alalla Z; Abu-Elmagd M; Abuzenadah A Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]